Aurobindo Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE406A01037
  • NSEID: AUROPHARMA
  • BSEID: 524804
INR
1,795.30
-11.7 (-0.65%)
BSENSE

Nov 20

BSE+NSE Vol: 8.25 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryAurobindo Pharma VS Pharmaceuticals & Biotechnology
 
1D
-0.65%
1.08%
1W
-1.84%
2.85%
1M
11.16%
13.63%
YTD
51.99%
-1.53%
1Y
48.57%
-2%
3Y
79.85%
27.82%
5Y
180.8%
40.72%
10Y
148.67%
220.91%
  • Stock Absolute Returns
  • Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.39%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
11.76%
0.43%
12.19%
6 Months
18.28%
0.48%
18.76%
1 Year
48.57%
0.57%
49.14%
2 Years
43.87%
0.88%
44.75%
3 Years
79.85%
1.22%
81.07%
4 Years
283.0%
4.10%
287.1%
5 Years
180.8%
3.61%
184.41%

Latest dividend: 7 per share ex-dividend date: Nov-11-2026

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
Return Quartiles - by Industry stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
Return Quartiles - by Market Cap stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
stock-summaryRisk Adjusted Returns v/s
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available